The Egyptian Journal of Internal Medicine

Table 6 Comparison between levels of Angiopoietin-2 before and 12 weeks after EOT according to fibrosis stages

From: Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs

		Angiopoietin-2		Differences		Paired Test
		Before treatment	12 weeks after treatment	Mean	SD	t	P-value
F0-F3	Range	240–720	110–700	77.879	76.598	5.841	<0.001*
F0-F3	Mean ±SD	375.455±140.492	297.576±171.647	77.879	76.598	5.841	<0.001*
F4	Range	830–1080	820–1000	18.571	28.536	1.722	0.136
F4	Mean ±SD	908.571±91.365	890.000±65.574	18.571	28.536	1.722	0.136
T-Test	t	−9.565	−8.917
T-Test	P-value	<0.001*	<0.001*

*significant

Back to article page